Mereo BioPharma Group Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018	2017	2016
Market Capitalization	436	297	88	174	243	47	-	-	-
Market Cap Growth	-	238.70%	-49.65%	-28.15%	419.63%	-	-	-	-
Enterprise Value	378	246	35	77	236	67	-8	-40	-63
PE Ratio	-10.09	-10.09	-2.08	10.95	-1.19	-1.07	-	-	-
PS Ratio	44.26	29.72	-	3.82	-	-	-	-	-
PB Ratio	7.00	5.88	1.71	1.58	-12.96	0.93	-	-	-
P/FCF Ratio	-14.06	-14.06	-1.80	-24.14	-6.84	-0.81	-	-	-
P/OCF Ratio	-14.06	-14.06	-1.80	-26.61	-6.85	-0.81	-	-	-
EV/Sales Ratio	37.82	24.57	-	1.70	-	-	-	-	-
EV/EBITDA Ratio	-8.99	-8.99	-0.88	3.27	-1.19	-1.52	0.18	0.69	1.51
EV/EBIT Ratio	-8.65	-8.65	-0.86	3.39	-1.18	-1.45	0.18	0.69	1.50
EV/FCF Ratio	-11.63	-11.63	-0.72	-10.71	-6.65	-1.16	0.26	0.99	1.70
Debt / Equity Ratio	0.12	0.12	0.30	0.19	-1.20	0.81	0.66	0.33	0.04
Debt / EBITDA Ratio	-0.22	-0.22	-0.39	0.89	-0.11	-0.92	-0.64	-0.45	-0.09
Debt / FCF Ratio	-0.28	-0.28	-0.31	-2.90	-0.63	-0.71	-0.93	-0.65	-0.11
Quick Ratio	6.05	6.05	2.80	7.63	2.86	0.57	1.74	5.52	16.93
Current Ratio	6.72	6.72	3.09	7.92	3.47	1.02	2.13	6.57	18.94
Asset Turnover	0.14	0.14	0	0.39	0	0	0	0	-
Interest Coverage	-9.86	-9.86	-9.70	4.54	-25.08	-8.41	-8.80	-42.07	-186.59
Return on Equity (ROE)	-57.80%	-57.80%	-52.30%	34.80%	-1294.30%	-95.40%	-67.20%	-54.70%	-
Return on Assets (ROA)	-41.00%	-41.00%	-35.90%	13.40%	-219.10%	-45.30%	-39.20%	-42.40%	-
Return on Capital (ROIC)	-50.30%	-50.30%	-81.51%	-17.76%	-1633.76%	-54.38%	-63.55%	-54.43%	-43.92%
Earnings Yield	-6.66%	-9.92%	-48.12%	9.13%	-84.34%	-93.32%	-	-	-
FCF Yield	-5.98%	-7.11%	-55.66%	-4.14%	-14.62%	-123.07%	-	-	-
Buyback Yield / Dilution	-21.11%	-9.33%	-10.78%	-60.76%	-376.09%	18.21%	-	-	-
Total Shareholder Return	-21.11%	-9.33%	-10.78%	-60.76%	-376.09%	18.21%	-	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).